Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)
United Arab Emirates · Delayed Price · Currency is AED 1.020
-0.020 (-1.92%)
At close: Sep 2, 2026
ADX:JULPHAR Ratios and Metrics
Market cap in millions AED. Fiscal year is January - December.
Millions AED. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,178 | 1,352 | 1,502 | 888 | 1,340 | 2,126 | |
Market Cap Growth | -21.54% | -10.00% | 69.05% | -33.71% | -36.96% | 38.35% |
Enterprise Value | 1,116 | 1,381 | 2,396 | 1,820 | 2,114 | 2,768 |
Last Close Price | 1.02 | 1.17 | 1.30 | 0.77 | 1.16 | 1.84 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.39 | 7.85 | 33.67 | - | - | 33.01 |
Forward PE | 9.27 | 21.27 | 52.00 | 57.00 | 21.09 | 16.64 |
PS Ratio | 1.07 | 1.26 | 1.51 | 0.70 | 0.83 | 1.86 |
PB Ratio | 1.16 | 1.41 | 1.88 | 1.10 | 1.44 | 2.21 |
P/TBV Ratio | 1.22 | 1.48 | 2.12 | 1.37 | 1.77 | 2.73 |
P/FCF Ratio | 43.97 | 15.86 | 10.27 | 12.43 | - | 1180.90 |
P/OCF Ratio | 17.25 | 11.18 | 7.90 | 9.49 | 69.43 | 46.01 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.01 | 1.28 | 2.42 | 1.43 | 1.31 | 2.42 |
EV/EBITDA Ratio | 7.86 | 14.06 | 17.34 | 24.30 | 31.78 | 21.54 |
EV/EBIT Ratio | 11.83 | 25.48 | 52.09 | - | - | 66.70 |
EV/FCF Ratio | 41.66 | 16.21 | 16.38 | 25.46 | - | 1537.84 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.27 | 0.29 | 1.22 | 1.38 | 0.95 | 0.85 |
Debt / EBITDA Ratio | 1.92 | 2.45 | 5.35 | 9.48 | 8.57 | 5.60 |
Debt / FCF Ratio | 10.19 | 3.23 | 6.64 | 15.53 | - | 455.06 |
Net Debt / Equity Ratio | -0.07 | 0.01 | 1.00 | 1.10 | 0.83 | 0.66 |
Net Debt / EBITDA Ratio | -0.52 | 0.07 | 5.81 | 11.82 | 11.64 | 4.98 |
Net Debt / FCF Ratio | -2.65 | 0.08 | 5.49 | 12.38 | -17.43 | 355.72 |
Asset Turnover | 0.58 | 0.51 | 0.41 | 0.53 | 0.67 | 0.48 |
Inventory Turnover | 1.37 | 1.48 | 1.04 | 1.28 | 1.60 | 1.60 |
Quick Ratio | 2.03 | 1.62 | 1.11 | 1.13 | 1.17 | 1.18 |
Current Ratio | 3.04 | 3.12 | 2.26 | 2.26 | 2.44 | 2.32 |
Return on Equity (ROE) | 9.53% | 4.99% | -1.16% | -8.75% | -3.83% | 4.08% |
Return on Assets (ROA) | 3.12% | 1.61% | 1.18% | -0.63% | -0.74% | 1.09% |
Return on Invested Capital (ROIC) | 9.23% | 3.91% | 2.79% | -1.44% | -1.73% | 2.53% |
Return on Capital Employed (ROCE) | 7.00% | 4.20% | 3.00% | -1.40% | -1.60% | 2.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 8.23% | 12.74% | 2.97% | -11.15% | -2.19% | 3.03% |
FCF Yield | 2.27% | 6.30% | 9.74% | 8.05% | -3.31% | 0.08% |
Buyback Yield / Dilution | - | - | - | - | - | -9.21% |
Total Shareholder Return | - | - | - | - | - | -9.21% |